In this week’s episode, Mark and Marc discuss innovation in the life sciences industry, including the recent launch of Orange Grove’s portfolio company, Asalyxa Bio. Topics include: Remdesivir and Marc’s view on this experimental medicine for combatting effects of COVID-19 Why Marc decided to focus his professional life on funding innovations in health care and…
Read More
Virologist Warner Greene, MD, PhD is studying how the COVID-19 virus enters cells, and will screen a library of FDA-approved drugs to identify those that could be rapidly repurposed as a treatment to stop cellular entry and spread of the virus. Before the emergence of the pandemic, Dr. Green and his team focused on…
Read More
In this episode, we speak with Rich Boyer, MD, PhD who is a PGY-4 resident anesthesiologist at Massachusetts General Hospital in Boston. Rich has a unique background. He has a PhD in biomedical engineering, and an MD degree, both from Vanderbilt University. While matriculating at Vanderbilt, he worked with the institution to establish their pioneering…
Read More
Working in close collaboration at the University of Delaware’sDesign Studio, Co-Directors Whitney Sample &Associate Professor of Mechanical Engineering Jenni Buckley, PhDhave established a partnership based on mutual admirationand respect. While designers & engineers often bring different world views and personalities to their work which creates a level of tension, Jenni & Whitney can finish one…
Read More
In this first episode of a new series on COVID-19 launched as part of the “When Science Speaks” podcast (), I interview , PhD, President . Ali is both an expert in infectious diseases and a former high-level policy advisor in the U.S….
Read More